ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

Name: ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)
License: Public Domain

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

renalcellcarcinoma

renal cell carcinoma, papillary renal cell carcinoma type 1, papillary renal cell carcinoma type 2, chromophobe renal cell carcinoma, sarcomatoid renal cell carcinoma, xp11.2 translocation-related renal cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 201773
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.